Adamantane

Adamantane

SCHEMBL2284749

C1C2CC3CC1CC(C2)C3.C=CCN

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.60
GRIN2D O15399 2/20 0.35
GRIN3B O60391 2/20 0.35
GRIN1 Q05586 2/20 0.35
GRIN2A Q12879 2/20 0.35
GRIN2B Q13224 2/20 0.35
GRIN2C Q14957 2/20 0.35
GRIN3A Q8TCU5 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Allylamine SCHEMBL6144765 0.78
Allylamine SCHEMBL15197 0.78
Allylamine SCHEMBL6032547 0.78
Allylamine SCHEMBL11351826 0.74
Cyclohexane SCHEMBL2246753 0.74 ALDH1A1 (0.75) ALDH1A1
Cyclohexane SCHEMBL9284958 0.74 ALDH1A1 (0.75) ALDH1A1
Allylamine SCHEMBL169953 0.73
Allylamine SCHEMBL13256599 0.73
Allylamine SCHEMBL5891273 0.73
Allylamine SCHEMBL3369484 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112111260-B Displacement leading edge outburst locking agent system and preparation method thereof 西南石油大学 2022-06-24 CN disclosed
CN-112111260-A Displacement leading edge outburst locking agent system and preparation method thereof 西南石油大学 2020-12-22 CN disclosed
US-9938332-B2 Modified ghrelin peptides Kanagawa, Kenji (JP) 2018-04-10 US disclosed
US-9573986-B2 Modified ghrelin peptides KENJI KANGAWA (JP) 2017-02-21 US disclosed
US-8524871-B2 Modified gherlin peptides Kangawa, Kenji (JP) 2013-09-03 US disclosed
US-20130172251-A1 MODIFIED GHRELIN PEPTIDES KANGAWA KENJI (JP) 2013-07-04 US disclosed
EP-2119785-B1 Novel peptides KANGAWA KENJI (JP) 2013-03-13 EP disclosed
US-8227570-B2 Modified gherlin peptides Kanagawa, Kenji (JP) 2012-07-24 US disclosed
US-20110184153-A1 MODIFIED GHERLIN PEPTIDES KANGAWA KENJI 2011-07-28 US disclosed
US-20100240866-A1 MODIFIED GHERLIN PEPTIDES KANGAWA KENJI 2010-09-23 US disclosed
EP-1795598-B1 Novel peptides KANGAWA KENJI (JP) 2009-11-18 EP disclosed
EP-2119785-A1 Novel peptides Kangawa, Kenji (JP) 2009-11-18 EP disclosed
US-20090170763-A1 Modified gherlin peptides KANGAWA KENJI 2009-07-02 US disclosed
US-7385026-B1 Modified ghrelin polypeptides Kangawa, Kenji (JP) 2008-06-10 US disclosed
EP-1197496-B1 NOVEL PEPTIDES KANGAWA KENJI (JP) 2007-07-11 EP disclosed
EP-1795598-A1 Novel peptides Kangawa, Kenji (JP) 2007-06-13 EP disclosed
EP-1197496-A1 NOVEL PEPTIDES Kangawa, Kenji (JP) 2002-04-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110184153-A1 MODIFIED GHERLIN PEPTIDES GHSR, GHRHR, GHITM ALDH1A1 4867/4885GRIN2D 1219/4885GRIN3B 326/4885
US-20090170763-A1 Modified gherlin peptides GHSR, GHRHR, GHITM ALDH1A1 4867/4885GRIN2D 1219/4885GRIN3B 326/4885
US-20130172251-A1 MODIFIED GHRELIN PEPTIDES GHSR, GIPR, GHRHR ALDH1A1 4811/4885GRIN2D 931/4885GRIN3B 250/4885
US-20100240866-A1 MODIFIED GHERLIN PEPTIDES GHSR, GHRHR, GHITM ALDH1A1 4867/4885GRIN2D 1219/4885GRIN3B 326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.